POTUS IS RIGHT

​Author: Dr. Ghulam Mujtaba, New Jersey, US.
Professor of Pharmacology & Scholar in Medical Education​
M.S., M.D., Ed.D., FRSPH, FICPS.
​More about Author:
https://en.wikipedia.org/wiki/Gholam_Mujtaba

---

Discovering Priorities – Human Health Vs Household Economy

Worst Recession since Great Depression of 1929.  A reality heading in 2020.

Would China, and aid-recipient nations survive it?

A count-down!

The crash of the Wall Street in the year 1929, famously known as the Great Crash, was a major stock market setback that occurred in 1929. It started in September and ended up late in October.

Is 2020, a repeat of 1929?
At the economic front, YES; but on other fronts NO.
Reopening of the global economy requires threat of Covid-19 in terms of mortality rate, while lockdown risks sustaining the financial constraints with job losses, furloughs and daily wage earners.

PERILS IN POLICY PLANNING
The earnings to feed bread and butter, and the supply-demand balance of daily commodities including life saving drugs remain at risk due to lockdown of production units.
What can be foreseen in this lockdown is a fundamental question before policy planning?

PROFESSIONAL JUDGMENTS IN HEALTHCARE
To me, no matter how many protective measures are taken through social distancing or lockdowns, these non-pharmaceutical interventions hardly helps decline in morbidity rate.

The morbidity rate increases through mismanagement in drug regimen. The pharmaceutical intervention requires reevaluation.

Hydroxychloroquine in conjunction to azithromycin has produced beneficial effects in clinical practice, though it requires to be monitored to cardiac, diabetic and asthmatic patients.

Does that prohibit its use in patients without pre-existing conditions?
The mortality rate can be controlled in this grey area of treatment regimen. 

As a Clinical Pharmacologist, I must say that beneficial effects surpass the inimical effects in President Trump’s suggestion on the use of hydroxychloroquine with azithromycin. Cardiac, diabetic and asthmatic patients require close monitoring and clinical judgments before dosage design.

SHOULD LOCKDOWN CONTINUE?
I present a case where lockdown is not the answer based on social impacts in our societies. Let us face a reality and deal the threat with the tools available to us. I do not see a decrease in the number of COVID-19 cases in lockdowns. The virus will get exposed to most of us in the way it travels across the streets. There is no real protection including PPE and masks.
​
The antibodies, the immunoglobulins present in our bodies produce response to a foreign invasion, thus producing an immune response. I have seen the developing antibodies Ig responses to those exposed to COVID-19 in the plasma serum tests.

CONCLUSION:
Enough social distancing has been done. We succeeded in plunging mortality rate, but the economic and social impact has been monumental. There has to be a balance between the two, and those unaware of medical sciences should avoid expertise opinion on the subject. Non-pharmaceutical interventions do NOT supplant pharmaceutical interventions in human pathology.

---